Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00690469 · ClinicalTrials.gov registry record

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

A clinical trial, sponsored by Children's Oncology Group.

Completed
Registry status
234
Enrollment target

NCT00690469: Completed study, sponsored by Children's Oncology Group.

NCT00690469 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 234 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00690469 has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
234 participants
Enrollment target

Study Summary

This laboratory study is looking at genetic mutations and environmental exposure in young patients with retinoblastoma and in their parents and young healthy unrelated volunteers. Gathering information about gene mutations and environmental exposure may help doctors learn more about the causes of retinoblastoma in young patients.

Interventions

  • OTHER Laboratory Biomarker Analysis
  • OTHER Questionnaire Administration

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2008-06-02
Children's Oncology Group

342 total trials

What the finished NCT00690469 record still lists

NCT00690469 is an observational study that tracks outcomes without assigning an intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT00690469 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00690469 about?

NCT00690469 is a clinical study titled "Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers". This laboratory study is looking at genetic mutations and environmental exposure in young patients with retinoblastoma and in their parents and young healthy unrelated volunteers. Gathering information about gene mutations and environmental exposure may help doctors learn more about the causes of re...

What is the current status of trial NCT00690469?

This trial is currently completed. The enrollment target is 234 participants. The study started on 2008-06-02.

What interventions are being tested in trial NCT00690469?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).

Who is sponsoring clinical trial NCT00690469?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04942717 · 234 participants · NA

    Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

  • NCT05208671 · 234 participants · NA

    Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

  • NCT05444465 · 234 participants · NA

    Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

  • NCT05720338 · 234 participants · Phase 3

    Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00690469, the US trial registry maintained by the National Library of Medicine. NCT00690469 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.